Search
Unicycive Therapeutics Inc
UNCYAdd to Watchlist
5.730USD
+0.450+8.52%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
152.99MMarket Cap
LossP/E TTM
Unicycive Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Unicycive Therapeutics Inc is 6.27, ranking 347 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.54, which is -705.90% below the recent high of 15.42 and -91.12% above the recent low of -4.86.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.